J. Massague,"TGF.beta.Signaling: Receptors, Transducers, and Mad Proteins," Cell 85:947-950 (1996). |
Attisano et al., "Activation of the signaling by the activin receptor complex." Mol. Cell. Biol. 16:, 1066-1073 (1996). |
V. Wiersdorff et al., "Mad acts downstream Of Dpp receptors, revealing a differential requirement for dpp signaling in initiation and propagation of morphogenesis in the Drosophila Eye," Development 122:2153-2162 (1996). |
R. Weiser et al., "GS domain mutations that constitutively activate TGF.beta.R-1, the downstream signaling component in the TGF-.beta. receptor complex," EMBO J., 14:2199-2208 (1995). |
F. Liu et al., "A Human Mad Protein Acting As a BMP-regulated Transcriptional Activator," Nature 381:620-623 (1996). |
R. Derynck and Y. Zhang, "Intracellular Signalling: The Mad Way To Do It," Curr. Biol. 6:1226-1229 (1996). |
Raftery et al., "Genetic Screens to Identify Elements of the decapentaplegic Signaling Pathway In Drosophila," Genetics 139:241-254 (1995). |
Savage et al., "Caenorhabditis elegans genes sma-2, sma-3 and sma-4 define a conserved family of transforming growth factor .beta. Pathway Components," Proc. Natl. Acad. Sci . USA 93:790-794 (1996). |
Lagna et al., "Partnertship between DPC4 and SMAD proteins in TGF-.beta. singnaling pathways," Nature 383:832-836 (1996); |
Hoodless et al., "MADRI, a MAD-Related Protein That Functions In BMP2 Signaling Pathways," Cell 85:489-500 (1996). |
Baker and Harland, "A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway," Genes Dev. 10:1880-1889 (1996). |
Vrana et al.,"Expression of Tissue Factor in Tumor Stroma Correlates with Progression to invasive Human Breast Cancer: Paracrine Regulation by Carcinoma Cell-derived Members of the Transforming Growth Factor .beta. Family," Cancer Res. 56(21):5063-5070 (1996). |
Mercier et al., "Calcitriol and Lexicalcitol (KH1060) Inhibit the Growth of Human Breast Adenocarcinoma Cells by Enhancing Transforming Growth Factor-.beta. Production," Biochem. Pharmacol. 52(3):505-510 (1996). |
Dannecker et al., "Induction of TGF-beta by an antiprogestin in the human breast cancer cell line T-47D," Ann. of Onco. 7(4):391-395 (1996). |
Kong, "Elevated Plasma Transforming Growth Factor-.beta..sub.1 Levels in Breast Cancer Patients Decrease After Surgical Removal of the Tumor," Ann. Surg. 222(2):155-162 (1995). |
Robson et al., "Transforming growth factor .beta.1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients," Brit. J. Cancer. 74(5):753-758 (1996). |
Tsushima et al., "High Levels of Transforming Growth Factor .beta.1 in Patients With Colorectal Cancer: Assocation With Disease Progression," Gastroenterol. 110(2):375-382 (1996). |
Akiyama "Transforming Growth Factor .beta. Type II Receptor Gene Mutations in Adenomas From Hereditary Nonpolyposis Colorectal Cancer," Gastroenterol. 112(1):33-39 (1997). |
Souza et al., "A Transforming Growth Factor .beta.1 Receptor Type II Mutation in Ulcerative Colitis-Associated Neoplasms," Gastroenterol. 112(1):40-45 (1997). |
Togo et al,, "A Transforming Growth Factor .beta. Type II Receptor Gene Mutation Common in Sporadic Cecum Cancer with Microsatellite Instability," Cancer Res. 56(24):5620-5623 (1996). |
Fakhrai et al., "Eradication of established intracranial rat gliomas by transforming growth factor .beta. antisense gene therapy," Proc. of the Natl. Acad. of Sci. USA 93(7):2909-2914 (1996). |
Weller and Fontana, "The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-.beta., T-cell apoptosis, and the immune privilege of the brain," Brain Res. Rev. 21(2):128-151 (1995). |
Perry et al., "Transforming Growth Factors Beta as a Clinical Biomarker for Prostate Cancer," Urology 49(1):151-155 (1997). |
Roberson et al., "Fenretinide: Induction of Apoptosis and Endogenous Transforming Growth Factor .beta. in PC-3 Prostate Cancer Cells," Cell. Growth and Diff. 8(1):101-111 (1997). |
Junker et al., "Transforming Growth Factors Beta 1 is Significantly Elevated in Plasma of Patients Suffering from Renal Cell Carcinoma," Cytokine 8(10):794-798 (1996). |
M. R. Keeton et al.. "Identification of the regulatory sequences in the type 1 Plasinogen Activator Inhibitor Gene Rresponsive to Transforming Growth Factor .beta.," J. Biol. Chem. 34: 23048-23052. |
Wrana et al., "TGF-.beta. signals through a heterotrimeric protein kinase receptor complex," Cell 71: 1003-1014 (1992). |
R. P. deGroot and W. Kruijer, "Transcriptional activation by TGF.beta.1 mediated by the dyad symmetry element (DSE) and the TPA responsive element (TRE)," Biochem. Biophys. Res. Commun. 168:1074-1081(1990). |
Chen et al., "A transcriptional partner for MAD proteins in TGF-.beta. signalling," Nature 383:691-695 (1996). |
Li et al., "Transforming Growth Factor .beta.Activates the promoter of Cyclin-dependent kinase inhibitor p15.sup.INK4B through an Sp1 consensus site," J.Biol.Chem. 270:26750-26753, (1995). |
R. Derynck et al., "Nomenclature: Vertebrate Mediators of TGF.beta. Family Singnals," Cell, 87:173 (1996). |
J. Sekelsky et al., "Genetic Characterization And Cloning Of Mothers Against Dpp, A Gene Required For Decapentaplegic Function In Drosophila Melanogaster," Genetics 139:1347-1358 (1995). |
Marmur and Lane, "Strand Separation and Specific Recombination in Deoxyribonucleic Acids: Biological Studies," Proc. Natl. Acad. Sci. USA 46:453-461 (1960). |
Doty et al., "Strand Separation and Specific Recombination in Deoxyribonucleic Acids: Physical Chemical Studies," Proc. Natl. Acad. Sci. USA 46:461-476 (1960). |
Wallace et al.,"Application of Synthetic Oligonucleotides to the Diagnosis of Human Genetic Diseases," Biochimie 67:755-762 (1985). |
Studencki and Wallace," Allele-Specific Hybridization Using Oligonucleotidee Probes of Very High Specific Acitvity: Discriminaation of the Human .beta..sup.A -and .beta..sup.A -Globin Genes," DNA 3: 7-15 (1984). |
Studencki et al., "Discrimination Among the Human .beta..sup.A, .beta..sup.S, and .beta..sup.C -Globin Genes Using Allele-Specific Oligonucleotide HydridizationProbes," Human Genetics 37:42-51 (1995). |
Smith and Waterman,"Comprison of Biosequences," Adv. Appl. Math. 2: 482-489 (1981). |
Needleman and Wunsch, "A General Method Applicable too the Search for Similarities in the Amino Acid Sequence of Two Proteins," J. Mol. Biol. 48:443-453 (1970). |
Pearson and Lipman, "Improved Tools for Biolgical Sequence Comparison," Proc. Natl. Acad. Sci. (U.S.A.)85: 2444-2448 (1988). |
Y. Zhang edt al., "Receptor-associated Mad Homologues Synergize As Effectors Of The TGF-beta Response," Nature 383:168-172 (1996). |
Bowie et al., "A Method to Identify Protein Sequences The Fold in to a Known Three-Dimensional Structure," Science 253:164-170 (1991). |
Thorton et al., "Prediction of progress at last," Nature 354:105-106 (1991). |
Fauchere, J., "Elements for the Rational Design of Peptide Drugs," Adv. Drug. Res. 15:29-67 (1986). |
Veber and Freidinger, "The design of metabolically-stable peptide analogs," TINS p.392-396 (1985). |
Evans et al., "Design of Nonpeptidal Ligands for a Peptide Receptor: Cholecystokinin Antagonists," J. Med. Chem 30:1229-1239 (1987). |
Rizo & Gierasch, "Constrained Peptides: Models of Bioactive Peptides and Protein Substructures," Ann. Rev. Biochem. 61:387-418 (1992). |
Cui et al., "TGF.beta.1 Inhibits the Formation of Bening Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Ttansgenic Mice," Cell 86:531-542 (1996). |
Border and Ruoshlahti, "Transforming Growth Factor-.beta. in Disease: The Dark Side of Tissue Repair," J. Clin. Invest., 90:1-7 (1992). |
Wahl, "Transforming Growth Factor-Beta (TGF-.beta.) in Inflmmation: A Cause and a Cure," J. Clin. Immunol. 12(2):61-74 (1992). |
Kuhn and Schwenk, Advances in gene targeting methods, Current Opin. Immunol. 9: 183-188. |
Massague and Weis-Garcia, "Serine/threonine Kkinase Receptors: Mediators of Transforming Growth Factor Beta family Signals," Cancer Surveys 27:41-64 (1996). |
Sinha et al., "Polymer support oligonucleotide synthesis XVIII: use of .beta.-cyanoethy1-N, N-dialklamino-/N-morpholino phosphoramidite of deoxynucleosides for the synthesis of DNA fragments simplifying deprotection and isolation of the final product," Nucleic Acids Res. 12:4539-4567 (1984). |
Kadonaga and Tijan,"Affinity purification of sequence-specific DNA binding proteins," Proc. Natl. Acad. Sci. (U.S.A.) 83:5889-5893 (1986). |
LeTilly & Royer, "Fluorenscence Anisotropy Assays Implicate Protein-Protein Interactions in Regulating trp Repressor DNA Binding," Biochem. 32:7753-7758 (1993). |
Linn and Riggs, "lac Repressor binding to Non-operator DNA: Detailed Studies and a Comparison of Eqilibrium and Rate Competition Methods," J. Mol. Bio 72:671-690 (1972). |
Fried and Crothers, "Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis," Nucleic Acids Res. 9(23):6506-6524 (1981). |
Riggs et al., "lac Repressor-Operator Interaction," J. Mol. Bio.; 48:67-83 (1970). |
Garner and Revzin, "A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Echerichia coli lactose operon regulatory system," Nucleic Acids Res. 9:3047-3060 (1981). |
Wang and Reed, "Molecular cloning of the olfactory neuronal transcription factor Olf-1 by genetic selection in yeast," Nature 364: 121-126 (1993). |
Alexandre et al., "Study Heterologous Transcription Factors in Yeast," Methods 5: 147-155 (1993). |
Luo et al., "Cloning and analysis of DNA-binding proteins by yeast one-hybrid systems," Biotechniques, 20: 564-8 (1996). |
Fields and O. Strong, "A novel genetic system to detect protein-protein interactions," Nature 340:245-246 (1989). |
D. J. Lockhart et al., "Expression monitoring by hybridisation to high-density oligonucleotide arrays," Nat. Biotech. 14:1675-1680 (1996). |
Mcpharron et al., "Regulation of skeletal muscle mass in mice by a new TGF-.beta. superfamily member," Nature, 387: 83-90 (1997). |
Gould et al., "Targets of homeotic gene control in Drosophila ," Nature 348: 308-312 (1990). |
Xu and Rubin, "Analysis of Genetic mosaics in developing and adult Drosophila tissues," Development, 117:1223-1237 (1993). |
Williams et al., "Pattern formation in a secondary field: a hierarchy of regulatory genes subdivides the developing Drosophila wing disc into discrete subregions," Development 117:571-584 (1993). |
Nelson & A. Laughon, "Drosophila glial architecture and development: analysis using a collection of new cell-specific markers," Roux Arch. dev. Biol. 202:341-354 (1993). |
Rubin and Spralding, "Genetic Transformation of Drosophila with Transposable Elements Vectors," Science 218:348-353 (1982). |
S. Blair, "Compartment And Appendage Development In Drosophila, " BioEssays 17(4):229-309 (1995). |
K. Basler and G. Struhl, "Compartment Boundaries And The Control of Drosophila Limb Pattern by Hedgehog Protein," Nature 368:208-214 (1994). |
T. Tabata and T. Kornberg, "Hedgehog Is A Signaling Protein With A Key Role In Patterning Drosophila Imaginal Discs," Cell 76:89-102 (1994). |
Zecca et al., "Sequential Organizing Activities of Engrailed, Hedgehog and Decapentaplegic in the Drosophila Wing," Development 121:2265-2278 (1995). |
W. Ingram and M.J. Fietz "Quantitative Effects of Hedgehog and Decapentaplegic Activity on the Patterning of the Drosophila Wing," Curr. Biol. 5:432-440 (1995). |
L. Posakony et al., "Wing Formation In Drosophila Melanogaster requires decapentaplegic gene function along the anterior-posterior compartment boundary," Mech. Dev. 33:69-82 (1991). |
Capdevilla, J. & Guerrero, I., "Targeted expression of the signalling molecule decapentaplegic induces pattern duplications and growth alterations in Drosophila wings," EMBO J. 13, 4459-4468 (1994). |
Nellen, D. et al. "Direct and Long-Range Action of A Dpp Morphogen Gradient," Cell 85, 357-368 (1996). |
Lecuit, T. et al., "Two distinct mechanisms for long-range patterning by Decapentaplegic in the Drosophila wing," Nature 381:387-393 (1996). |
Kim., J. et al, "Integration of positional signals and regulation of wing formation and identity by Drosophila vestigial gene," Nature 382:133-138 (1996). |
de Celis, J. Fet et al., "A gene complex acting downstream of dpp in Drosophila wing morphogenesis," Nature 381, 421-424 (1996). |
Grimm, S. and Pflugfleder, G. O., "Control of the Gene optomotor-blind in Drosophila Wing Development by decapentaplegic and wingless," Science, 271, 1601-1604 (1996). |
K. Eppert et al., "MADR2 Maps to 18q21 and Encode a TGF beta-regualted MAD-related Protein That is Functionally Mutated in Colorectal Carcinoma," Cell 86:543-552 (1996). |
Chouinard, S. & Kaufman, T. C., "Control of expression of the homeotic labial ( lab ) locus of Drosophila melanogaster: evidence for both positive and negative autogenous regulation," Development 13: 1267-1280 (1991). |
Tremml, G. & Bienz, M., "Induction of labial expression in the Drosophia endoderm: response elements for dpp signalling and for autoregulation," Development 116:447-456 (1992). |
Thuringer, F., et al, "Dissection of an indirect autoregulatory response of a homeotic Drosophila gene," EMBO J. 12:2419-2430 (1993). |
Chen et al., "A transcriptional partner for MAD proteins in TGF-.beta. signalling," Nature 383:691-696 (1996). |
Y. Zhang et al., "Tumor Suppressor Smad4/DPC4 as a Central Mediator of Smad Function," Current Biology 7:270-276 (1977). |
M. Kretzschmar et al., "The TGF-.beta. Family Mediator Smad1 is Phosphorylated Directly and Acitvated Funcitonally by the BMP Receptor Kinase" Genes & Development 11:984-995 (1997). |
Mastick et al., "Identification of Targets Genes Regulated by Homeotic Proteins in Drosophila melanogaster Through Genetic Selection of Ultrabithorax Protein-Binding Sites in Yeast," Genetics 139:349-363 (1995). |
D.A. Cox, "Transforming Growth Factor-Beta 3," Cell Biology International 19:357-371 (1997). |
J. Rusch and M. Levine, "Regulation of a dpp target gene in the Drosophila embryo", Development 124:303-311 (1997). |
Kim S-J et al., "Characterization of the promoter region of the human transforming growth factor-.beta.1 gene," J. Biol. Chem. 264(1):402-408 (1989). |
Macias-Silva et al., "MADR2 is a substrate of the TGF-.beta. receptor and its phosphorylation is required for nuclear accumulation and signaling" Cell 87:1215-1224 (1996). |
Graba, Y. et al., "Hometic control in Drosophila; the scabrous gene is an in vivo target of Ultrabithorax ( Ubx ) proteins", EMBO J. 11(9):3375-3384 (1992). |
Graff, J.M. et al., "Xenopus Mad proteins transduce distinct subsets of signals for the TGF-.beta. superfamily", Cell 85:479-487 (1996). |
Liu et al. Jun. 13, 1996. Nature 381: 620-623. |
Ayer et al. 1993. Cell 72: 211-222 |
Sekelsky et al. 1995 Genetics 139: 1347-1358 |